Results 161 to 170 of about 52,757 (299)

Prostatitis syndromes and benign prostatic hyperplasia

Seminars in Roentgenology, 1999
S R, Potter, A W, Partin
openaire   +2 more sources

Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men. [PDF]

J Glob Health
Li H, Zhang Y, Chen L, Yuan J, Qin F, Wang X, Xiong Y.   +6 more
europepmc   +1 more source

Targeting fibrosis in the treatment of lower urinary tract dysfunction

The Journal of Pathology, Volume 269, Issue 4-5, Page 493-503, August 2026.
Abstract Benign prostatic hyperplasia (BPH) is a widely prevalent age‐associated disease that is the main contributor to lower urinary tract dysfunction (LUTD) in aging men. Although prostate fibrosis has been recognized as a contributor to BPH pathophysiology, there are not any clinically available therapeutics that target this aspect of disease ...
Ajinkya R Limkar, Sophia M Vrba, Emily A Ricke, Zsuzsanna Fabry, Matthew S Lee, Kevin T McVary, William A Ricke   +6 more
wiley   +1 more source

Screening for prostatic cancer: the case for. [PDF]

, 1993
Liedke, S. G., Kuczyk, M., Stief, Christian Georg, Allhoff, E. P.   +3 more
core   +1 more source

Minimally invasive treatments for benign prostatic hyperplasia: A narrative review. [PDF]

Medicine (Baltimore)
Zhang X, Liang T, Dong Y, Gao H.
europepmc   +1 more source

Association Between Kamikihito Treatment and Nocturnal Voiding Frequency in Patients With Sleep Disturbance: A Retrospective Clinical Study

Traditional &Kampo Medicine, Volume 13, Issue 2, August 2026.
ABSTRACT Aim Sleep disturbance is an important contributing factor to nocturia, particularly in older adults. Kamikihito is a Kampo medicine traditionally prescribed for the Heart and spleen systems deficiency pattern (TM1). The aim of this study was to retrospectively evaluate the association between kamikihito treatment and nocturnal voiding ...
Shigehisa Kubota, Masayuki Nagasawa, Akinori Wada, Kenichi Kobayashi, Kazuaki Yamanaka, Tetsuya Yoshida, Kazuyoshi Johnin, Susumu Kageyama   +7 more
wiley   +1 more source

Rice bran oil ameliorates the symptoms of benign prostatic hyperplasia in male Wistar rats. [PDF]

Avicenna J Phytomed
Miah MA, Sathi MA, Hasib MG, Rahman M, Mahmud N, Shill MC, Reza HM, Hossain M, Rahman MM, Mostaid MS.   +9 more
europepmc   +1 more source

Association Between Trial Duration and Completion Rate in Men's Health Clinical Trials, 2005–2024

Trends in Urology &Men's Health, Volume 17, Issue 4, August 2026.
ABSTRACT Clinical trials drive evidence generation in men's health, yet temporal patterns in trial duration and completion remain poorly characterized. We examined relationships between trial duration, completion rates, and trial characteristics in men's health research registered over two decades.
Thriaksh Rajan, Mahan Miryala, Thomas Syphan, Kyle Scarberry, Adonis Hijaz, Ramy Abou Ghayda   +5 more
wiley   +1 more source

Relation of Prostatic and Urinary Bladder Ultrasound Parameters in Patients With Benign Prostatic Hyperplasia. [PDF]

Health Sci Rep
Pokharel BP, Thapa NB, Singh J, Dangi Y, Singh DB.   +4 more
europepmc   +1 more source

Ejaculatory Dysfunction and Minimally Invasive Surgical Treatments (MIST) for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement

Trends in Urology &Men's Health, Volume 17, Issue 4, August 2026.
ABSTRACT While transurethral resection of the prostate (TURP) is considered the standard surgical treatment in symptomatic benign prostatic enlargement (BPE) secondary to benign prostatic hyperplasia (BPH), it is not without surgical morbidities and has adverse impact on various sexual function domains such as ejaculatory dysfunction (EjD) and erectile
Haijun Yao, Tao Wang, Shan‐Chao Zhao, Lei Zheng, Rui Jiang, Han Wu, Jingjing Gao, Baibing Yang, Yuzhuo Yang, Haocheng Lin, Eric Chung   +10 more
wiley   +1 more source